News

May 28, 2020
IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference
MOUNTAIN VIEW, Calif. , May 28, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present at the Jefferies 2020
Additional Formats
March 4, 2020
IGM Biosciences to Present at Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. , March 04, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that members of the management team will present at two upcoming investor
Additional Formats
February 6, 2020
IGM Biosciences to Present at Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a global leader in the research and development of engineered therapeutic IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present at two upcoming investor conferences:
Additional Formats